Abstract
BackgroundTofacitinib is an oral JAK inhibitor for the treatment of RA.ObjectivesTo evaluate tofacitinib 5 and 10 mg twice daily (BID) efficacy in patients (pts) with moderate vs severe RA.MethodsTofacitinib 5...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have